COVID Delta is fueling greater marijuana sales, a dynamic reflected by the soaring popularity of other so-called sin stocks. Read More
John Persinos is the editorial director of Investing Daily, overseeing such publications as Personal Finance, Utility Forecaster, Profit Catalyst Alert, Rapier's Income Accelerator, Income Forecaster, and Marijuana Investing Daily, among others. John also writes the Mind Over Markets daily stock market recap, and he's the chief investment strategist of Marijuana Profit Alert.
John has decades of experience in the technology and political realms. He has worked as a staff editor at Inc. and Venture magazines, and written for Kiplinger's, Street Authority, Investing Answers, and TheStreet.com, to name a few. In a career that has spanned more than 40 years, John has been diligently and prolifically covering the news and its impact on investors.
John also has experience with the inner-workings of Capitol Hill, serving as a press secretary to U.S. Rep. Byron Dorgan (D-ND). John started his career as a daily newspaperman with The Orlando Sentinel.
John holds undergraduate and graduate degrees from Boston University. He also completed the Davenport Fellowship in Business and Economics Reporting at the University of Missouri (Columbia).
Analyst Articles
Economic growth and robust corporate earnings are keeping stocks afloat, but beneath the surface the virus mutation still lurks as a danger. Read More
The White House this week announced a major boost for the electric vehicle industry. Here’s how investors should play the news. Read More
The combination of progressive laws, affluent consumers, and tolerant attitudes is making the Old World a new source of cannabis growth. Read More
Does the bull market still have legs, or are conditions worse than the optimists think? We put aside the spin and weigh the facts. Read More
The pandemic is resurgent, but corporate profits are robust enough to push stocks higher. Here are the cold hard numbers behind the rally. Read More
An increasing number of states and localities are decriminalizing magic mushrooms, LSD, and a host of other psychotropics. Big profits are at stake. Read More
There’s a revolution occurring in biotechnology that’s about to mint a new breed of millionaire. Here’s how to profitably leverage the trend. Read More
August is typically a time of lazy summer vacations, but investors shouldn't get too comfortable in their beach chairs. Risks are heating up. Read More
In Wall Street’s expectations game, analysts sometimes view good news as bad, and vice versa. Here’s how to stay forward looking. Read More